The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.
Respiratory syncytial virus (RSV) infects the upper and lower respiratory tracts and can cause lower respiratory tract infections in children and elders. RSV has traditionally been isolated, grown, studied and quantified in immortalized cell lines, most frequently HEp-2 cells. However, in vivo RSV i...
Saved in:
Main Authors: | Tiffany King, Asuncion Mejias, Octavio Ramilo, Mark E Peeples |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a3d5bf5276134086b1d24e01dc056af9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.
by: Manuel Mata, et al.
Published: (2013) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
by: Asunción Mejías, et al.
Published: (2008) -
Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.
by: Asuncion Mejias, et al.
Published: (2013) -
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
by: Daiyin Tian, et al.
Published: (2017) -
Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells
by: Vincent Wellemans, et al.
Published: (2021)